Inventor · disambiguated record
Stephen Critchley
Also filed as: CRITCHLEY STEPHEN
7 granted patents·5 pending applications·85 citations·filing 2006–2020
86Inventor score
Top patents by PatentIndex Score
12 records- 0197US8008307B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2007·Granted Aug 30, 2011·25 cites·17 claims
- 0295US8481550B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jul 9, 2013·19 cites·14 claims
- 0394US9150525B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2014·Granted Oct 6, 2015·10 cites·19 claims
- 0493US8901136B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·12 cites·9 claims
- 0592US7951810B2Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2006·Granted May 31, 2011·16 cites·19 claims
- 0688US9458108B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2015·Granted Oct 4, 2016·3 cites·18 claims
- 0770US2021070798A1Inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2020·Application pending·0 cites
- 0867US9718788B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2016·Granted Aug 1, 2017·0 cites·1 claims
- 0966US2017073367A9Substituted pyrrolo[2,3-d]pyrimidinesMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 1062US2014256668A9Substituted pyrrolo]2,3-d]pyrimidinesMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 1162US2018086785A1Substituted pyrrolo[2,3-d]pyrimidinesMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 1257US2011136834A1Inhibitors of e1 activating enzymesMILLENNIUM PHARM INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Critchley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →